Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP12.01 - Patient Advocacy
- Type: E-Poster
- Track: Patient Advocacy
- Presentations: 1
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP12.01-001 - What Do Patients Want - a European Study Into ALK-Positive Patients Perspectives
Author(s): Jamie Gibbard- Abstract
Loading...
-
+
EP13.01 - Pulmonology, Radiology, and Staging
- Type: E-Poster
- Track: Pulmonology, Radiology, and Staging
- Presentations: 17
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP13.01-009 - A Modified T Categorization for Pathological Stage I Lung Adenocarcinoma with Lepidic Component in Chinese Population
Author(s): Shenghui Li- Abstract
Loading... -
+
EP13.01-001 - The Burden of Incidental Extra-thoracic Positron Emission Tomography-CT (PET-CT) Findings in Thoracic Malignancies
Author(s): Dana Li- Abstract
Loading... -
+
EP13.01-005 - Role of Artificial Intelligence on Chest Radiographs for Detecting Resectable Early Lung Cancer
Author(s): Eunhye Lee- Abstract
Loading... -
+
EP13.01-013 - Determination of the Timing of Bevacizumab Administration in Osimertinib and Bevacizumab Combination Therapy
Author(s): Fei Teng- Abstract
Loading... -
+
EP13.01-014 - Evaluation of Malignancy and Survival in Patients Operated With a Preliminary Diagnosis of Interstitial Lung Disease
Author(s): Gizem Kececi Ozgur- Abstract
Loading... -
+
EP13.01-007 - Differentiation between heterogeneous GGNs and part solid nodules using histogram on thin-section CT.
Author(s): Hirofumi Koike- Abstract
Loading... -
+
EP13.01-004 - Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)
Author(s): Hye Ran Gwon- Abstract
Loading... -
+
EP13.01-006 - Safety of Image Guided Research Biopsies in Patients with Thoracic Malignancies
Author(s): Jia Luo- Abstract
Loading... -
+
EP13.01-003 - Diagnostic Yield of Radial Probe Endobronchial Ultrasonography without Fluoroscopic guidance in Peripheral Pulmonary Lesions
Author(s): Joonhee Han- Abstract
Loading... -
+
EP13.01-010 - Effect of Perioperative Respiratory Muscle Training with Gamification for Lung Cancer
Author(s): Masao Saito- Abstract
Loading... -
+
EP13.01-011 - Combining Automated Malignancy Risk Estimation with Lung Nodule Detection May Reduce Physician Effort and Increase Diagnostic Accuracy
Author(s): Michael E Calhoun- Abstract
Loading... -
+
EP13.01-012 - Exploring Factors Affecting Variability in Lung Cancer Outcomes Across Southeastern Ontario, Canada
Author(s): Shahad AlGhamdi- Abstract
Loading... -
+
EP13.01-016 - Are Follow-up Tests Useful in NSCLC? Experience of a Tertiary Hospital
Author(s): Fernando Cano- Abstract
Loading... -
+
EP13.01-008 - Needle Aspiration versus Forceps Biopsy Using Electromagnetic Navigation Bronchoscopy: CONFIDENT-ENB Trial Design
Author(s): Yeon Wook Kim- Abstract
Loading... -
+
EP13.01-002 - Radiomic Signature on CT Images: A Noninvasive Biomarker for Pretreatment Discrimination of EGFR Mutations in NSCLC Patients
Author(s): Yusuf Kahya- Abstract
Loading... -
+
EP13.01-017 - Assessing Variance Between Radiology versus Multidisciplinary Clinic Recommendations in the Pulmonary Nodule and Lung Screening Clinic
Author(s): Elise Noonan- Abstract
Loading... -
+
EP13.01-015 - Correlation Between CT Signs and Ki67 Expression in Non-small Cell Lung Cancer
Author(s): Yuanyong Wang- Abstract
Loading...
-
+
EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- Presentations: 23
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.01-019 - Identifying Circulating DNA Methylation Patterns in Small Cell Lung Cancer Patients
Author(s): Sami Ul Haq- Abstract
Loading... -
+
EP14.01-008 - Checkpoint Inhibitors Prevent New Onset of Brain Metastases in Relapsed Extensive Disease Small-Cell Lung Cancer
Author(s): Jan Alexander Stratmann- Abstract
Loading... -
+
EP14.01-002 - Efficacy and Safety of Tiselizumab Combined with Anlotinib and 2-cycle Irinotecan as Second-line Treatment of Small Cell Lung Cancer
Author(s): xian chen- Abstract
Loading... -
+
EP14.01-023 - A Randomized Phase II Study of Irinotecan Plus Cisplatin With or Without Simvastatin in Ever-Smoking Small Cell Lung Cancer
Author(s): Youngjoo Lee- Abstract
Loading... -
+
EP14.01-021 - Anlotinib Plus Irinotecan or Docetaxel in Small-Cell Lung Cancer (SCLC) Relapsed within Six Months: a Single-Arm Phase II Study
Author(s): Bing Xia- Abstract
Loading... -
+
EP14.01-014 - Risk Factors for Brain Metastasis in Patients with Small Cell Lung Cancer: A Systematic Review and Meta-analysis
Author(s): Haiyan Zeng- Abstract
Loading... -
+
EP14.01-005 - Weekly Sequential ACOCEV Chemotherapy (ADR, CTX, CBDCA, VP16, VCR) for Elderly - Poor PS SCLC Patients: An Observational Study
Author(s): Antonio Santo- Abstract
Loading... -
+
EP14.01-001 - SCLC Transformation from ALK-rearranged Lung Adenocarcinoma after Alectinib Resistance and Response to Atezolizumab: Case Report
Author(s): Guohao Xia- Abstract
Loading... -
+
EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC
Author(s): Luis Paz-Ares- Abstract
Loading... -
+
EP14.01-007 - Next-Generation Sequencing to Dynamically Detect Mechanisms of Resistance to ALK Inhibitors in ALK-positive SCLC Patient: A Case Report
Author(s): Renhong Guo- Abstract
Loading... -
+
EP14.01-010 - CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
Author(s): Ying Cheng- Abstract
Loading... -
+
EP14.01-016 - Anlotinib Plus Toripalimab as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: a Single-Arm Phase II Study
Author(s): Dongqing Lv- Abstract
Loading... -
+
EP14.01-006 - CeLEBrATE: Phase II trial of CarbopLatin, Etoposide, Bevacizumab and Atezolizumab in Patients with exTEnsive-Stage SCLC-GOIRC-01-2019
Author(s): Elisa Andrini- Abstract
Loading... -
+
EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer
Author(s): Stephen V. Liu- Abstract
Loading... -
+
EP14.01-018 - Small Cell Lung Carcinoma in Morocco
Author(s): Ouassima Erefai- Abstract
Loading... -
+
EP14.01-009 - A Comparative Study of Histological Predictors of Outcome in Patients with Lung Typical and Atypical Carcinoids
Author(s): Joana Rei- Abstract
Loading... -
+
EP14.01-013 - First-Line Chemotherapy vs Chemoimmunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung, a Retrospective Study
Author(s): Lingbin Meng- Abstract
Loading... -
+
EP14.01-011 - Carcinoid Tumor of the Lung with Osteomimicry. Case Report
Author(s): Lovorka Batelja Vuletic- Abstract
Loading... -
+
EP14.01-003 - Parotid Metastases from Primary Lung Cancer: Case Series and Systematic Review on the Clinical Features
Author(s): Rulan Wang- Abstract
Loading... -
+
EP14.01-012 - A Case Report of Lung Large Cell Neuroendocrine Carcinoma with Carcinoid Morphology
Author(s): Lovorka Batelja Vuletic- Abstract
Loading... -
+
EP14.01-022 - Immune Thrombocytopenia in a Patient with Large Cell Neuroendocrine Carcinoma Under Dual Immune Checkpoint Inhibition
Author(s): Georgia Gomatou- Abstract
Loading... -
+
EP14.01-024 - Transformation of SCLC to Lung Squamous Cell Carcinoma after First-Line Chemotherapy and Response to Sintilimab: A Case Report
Author(s): Zhisheng Liu- Abstract
Loading... -
+
EP14.01-025 - Anlotinib Plus Standard Chemotherapy as First-line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
Author(s): Wei Zhang- Abstract
Loading...
-
+
EP14.02 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
- Presentations: 7
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.02-005 - Therapeutic targeting Mevalonate-Geranylgeranyl Diphosphate Pathway with Statins Overcomes Chemotherapy-resistance in SCLC
Author(s): Chenchen Guo- Abstract
Loading... -
+
EP14.02-006 - Subtype-specific Hypersensitivity to Oxidative Phosphorylation Inhibition in Small Cell Lung Cancer
Author(s): Kristiina Boettiger- Abstract
Loading... -
+
EP14.02-003 - Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Author(s): Christian Lang- Abstract
Loading... -
+
EP14.02-007 - Hes1 Protein Expression and Its Significance in Resected Small Cell Lung Cancers
Author(s): xujie Sun- Abstract
Loading... -
+
EP14.02-004 - Barasertib Inhibits the Growth of SCLC Cell Lines and Transformed SCLC Patient Derived Model In Vitro and In Viv
Author(s): Jin Soo Kim- Abstract
Loading... -
+
EP14.02-001 - Could the Oxidative Stress Be Used as a Marker for Neuroendocrine Lung Tumors?
Author(s): Luigi Gaetano Andriolo- Abstract
Loading... -
+
EP14.02-002 - Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer
Author(s): Anna Schwendenwein- Abstract
Loading...
-
+
EP14.03 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
- Presentations: 5
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.03-002 - Low-Dose Radiotherapy Plus Sugemalimab in Second-Line Treatment for Advanced-Stage Small-Cell Lung Cancer: Initial Results of a Phase I Study
Author(s): Youling Gong- Abstract
Loading... -
+
EP14.03-001 - DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive Stage Small Cell Lung Cancer
Author(s): Aditya Juloori- Abstract
Loading... -
+
EP14.03-003 - Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Author(s): Neal Sean Mccall- Abstract
Loading... -
+
EP14.03-004 - Neuro-cognitive Effect of HS-PCI in LS-SCLC
Author(s): Suryakanta Acharya- Abstract
Loading... -
+
EP14.03-005 - Role of Radiotherapy Fraction in Limited-Stage SCLC: a Meta-Analysis of 8585 Reconstructed Individual Patient Data
Author(s): Jingjing Zhao- Abstract
Loading...
-
+
EP14.04 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW
- Presentations: 2
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.04-001 - Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)
Author(s): Sara Mieko Moore- Abstract
Loading... -
+
EP14.04-002 - The Impact of Response on Survival in Extensive-Stage Small-Cell Lung Cancer in the CASPIAN Study
Author(s): Sukhvinder Johal- Abstract
Loading...
-
+
EP14.05 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
- Presentations: 23
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.05-023 - Characterization of Real-World Use of Lurbinectedin in Adult Small Cell Lung Cancer Patients in the United States
Author(s): Xue Wang- Abstract
Loading... -
+
EP14.05-006 - The Impact of Adjuvant Chemotherapy on Survival of Stage I Lung Large Cell Neuroendocrine Carcinoma: A Meta-Analysis of Comparative Studies
Author(s): Philip A Haddad- Abstract
Loading... -
+
EP14.05-003 - Recent Stage Shifts and Changes in the Treatment of Stage I Small Cell Lung Cancer in the United States
Author(s): Chinmay Satish Haridas- Abstract
Loading... -
+
EP14.05-020 - Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)
Author(s): Sara Mieko Moore- Abstract
Loading... -
+
EP14.05-007 - A Study of the Best Reduction in Target Lesion Size and Treatment Duration in the Durvalumab plus Platinum-Etoposide Regimen for ES-SCLC
Author(s): Kageaki Watanabe- Abstract
Loading... -
+
EP14.05-015 - Quantifying Recent Trends in Real-World Treatment Patterns Among Adults Diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021
Author(s): Paul Cockrum- Abstract
Loading... -
+
EP14.05-022 - The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer
Author(s): Rei Takamiya- Abstract
Loading... -
+
EP14.05-010 - Real-World Eligibility for Clinical Trials in Extensive Stage Small Cell Lung Cancer Patients
Author(s): Navdeep Dehar- Abstract
Loading... -
+
EP14.05-014 - Trends in Population Survival Among Adults Diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021
Author(s): Paul Cockrum- Abstract
Loading... -
+
EP14.05-001 - Chemoimmunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer and ECOG Performance Status of 2 or 3
Author(s): Muskan Agarwal- Abstract
Loading... -
+
EP14.05-018 - Major Lung Resection for Carcinoid Tumor; Does It Affect Quality of Life?
Author(s): riad abdeljalil- Abstract
Loading... -
+
EP14.05-017 - Real World Eligibility of Immune Checkpoint Inhibitors with Platinum-Doublet in Extensive Stage Small Cell Lung Cancer
Author(s): Rebekah Rittberg- Abstract
Loading... -
+
EP14.05-005 - Survival of Small Cell Lung Cancer in Relation to Chemotherapy Dose Intensity
Author(s): Elisa María Fernández Pérez- Abstract
Loading... -
+
EP14.05-016 - Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study.
Author(s): Joanna Huang- Abstract
Loading... -
+
EP14.05-008 - Development of a Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Using Next-Generation Sequencing
Author(s): Hye Sook Kim- Abstract
Loading... -
+
EP14.05-009 - LUMINANCE: A Phase IIIb Study of Durvalumab + Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
Author(s): Niels Reinmuth- Abstract
Loading... -
+
EP14.05-004 - Temozolomide and Atezolizumab as Second Line Treatment for Extensive Stage Small Cell Lung Cancer: A Randomized, Multi-Cohort Phase 2 Trial
Author(s): Dwight H Owen- Abstract
Loading... -
+
EP14.05-021 - Promising Long-Term Survival after Surgical Resection of Early Stage Small Cell Lung Cancer in a Modern Single-Center Cohort
Author(s): Sora Ely- Abstract
Loading... -
+
EP14.05-019 - Contemporary Real-World Adverse Events Associated with Small Cell Lung Cancer Diagnosed in a U.S. Population from 2013-2021
Author(s): Robert A Ramirez- Abstract
Loading... -
+
EP14.05-002 - Impact of Body Mass Index on Survival in Patients with Small Cell Lung Cancer
Author(s): Alejandro Rios-Hoyo- Abstract
Loading... -
+
EP14.05-011 - Real-World Impact of Platinum Sensitivity and Disease Stage on Survival Among Medicare Patients with Small Cell Lung Cancer
Author(s): Gabriela Dieguez- Abstract
Loading... -
+
EP14.05-013 - Real-World Resource Use and Costs by Stage and Platinum Sensitivity among Medicare Patients with Small Cell Lung Cancer
Author(s): Paul Cockrum- Abstract
Loading... -
+
EP14.05-012 - Comparing Costs for Medicare FFS Patients Treated with Etoposide or Irinotecan for Extensive Stage Small Cell Lung Cancer
Author(s): Rebecca Smith- Abstract
Loading...
-
+
EP15.01 - Tobacco Control and Risk Reduction
- Type: E-Poster
- Track: Tobacco Control and Risk Reduction
- Presentations: 2
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP15.01-002 - Lowering Rates of Smoking after Cancer Diagnosis: Use Social Networks
Author(s): Melissa Neumann- Abstract
Loading... -
+
EP15.01-001 - Ask, Advise, Help (AAH) Smoking Cessation Brief Advice Delivery in Patients with Diagnosed Lung Cancer: A Retrospective Audit
Author(s): John Lau- Abstract
Loading...
-
+
EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- Presentations: 31
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP16.01-015 - Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Author(s): Maximilian Johannes Hochmair- Abstract
Loading... -
+
EP16.01-003 - The Dynamic Immune Signature of Patients with Advanced Non-small Cell Lung Cancer in Prediction of Infection After Receiving Immunotherapy
Author(s): Chia-I Shen- Abstract
Loading... -
+
EP16.01-005 - Cilia-related mRNA Profile Predicts Clinical Response to PD-1 Blockade in Lung Adenocarcinoma
Author(s): Guanghui Gao- Abstract
Loading... -
+
EP16.01-006 - CD47 Inhibition Impairs the Growth of Orthotopic, Immune Competent Lung Tumour Models
Author(s): Asa Lau- Abstract
Loading... -
+
EP16.01-008 - The Effect of Cytochrome P450 Family 4 Subfamily B Member 1 (CYP4B1) on Lung Adenocarcinoma (LUAD) Immune Microenvironment
Author(s): Leen Al-Kraimeen- Abstract
Loading... -
+
EP16.01-013 - The Diagnostic Accuracy of Tumor Mutational Burden in Advanced NSCLC: An Individual Patient Data Meta-Analysis
Author(s): Maria La Mantia- Abstract
Loading... -
+
EP16.01-014 - Characterisation of Circulating Immune Cells in a Cohort of Non-small Cell Lung Cancer Patients Treated with Immunotherapy
Author(s): Marta Gascón- Ruiz- Abstract
Loading... -
+
EP16.01-011 - PD-L1 Expression on Cytological Imprints and Circulating Tumor Cells versus Standardized Immunohistochemistry in NSCLC
Author(s): Mustafa Abdo- Abstract
Loading... -
+
EP16.01-016 - Tumor Treating Fields (TTFields) Application Promotes a Pro-inflammatory Phenotype in Macrophages
Author(s): Yiftah Barsheshet- Abstract
Loading... -
+
EP16.01-017 - T-cell Repertoire Heterogeneity and Homogeneity in Synonymous Multiple Primary Lung Cancers
Author(s): Yadong Wang- Abstract
Loading... -
+
EP16.01-007 - Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
Author(s): Patricia Cruz Castellanos- Abstract
Loading... -
+
EP16.01-018 - SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC
Author(s): Dominic Schmid- Abstract
Loading... -
+
EP16.01-031 - Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
Author(s): Sena Valcárcel González- Abstract
Loading... -
+
EP16.01-024 - Differential Efficacy of Combined GITR Co-stimulation with PD-1 Blockade in Preclinical Non-small Cell Lung Cancer Models
Author(s): Sheng Yan- Abstract
Loading... -
+
EP16.01-010 - A Machine-Learning Based Survival Prediction for Lung Adenocarcinma by Analyzing Infiltrated Lymphocytes Profiles with CIBERSORT
Author(s): Tong Lu- Abstract
Loading... -
+
EP16.01-025 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
Author(s): Wen-Fang Tang- Abstract
Loading... -
+
EP16.01-020 - Predictive Effect of Spatial Protein Signature in Advanced NSCLC Receiving Immunotherapy with a Bispecific Antibody
Author(s): Xinyu Song- Abstract
Loading... -
+
EP16.01-021 - Less Immune Cell Infiltration and Worse Prognosis for NSCLC Patients with XPO1 Copy Number Alterations
Author(s): Xuanzong Li- Abstract
Loading... -
+
EP16.01-022 - A Signature of B Cells-Related Gene Pairs Predicts Oncologic Outcomes and Response to Immunotherapy in NSCLC Patients
Author(s): Xuanzong Li- Abstract
Loading... -
+
EP16.01-001 - Transforming Growth Factor-βinhibitsInterferon- γmediated Immune Resistance in Lung Cancer
Author(s): ye fan- Abstract
Loading... -
+
EP16.01-027 - MIF ImprovesImmune Microenvironmentof Lewis Lung Cancer Brain Metastases after Radiotherapy ViaReducing M2 Macrophages
Author(s): Ying Wang- Abstract
Loading... -
+
EP16.01-028 - Immunomodulatory Effects of Cryoablation Combined With Immune Checkpoint Inhibitors in a Murine Lung Cancer Model
Author(s): Yoshikane Yamauchi- Abstract
Loading... -
+
EP16.01-012 - Immunophenotyping of Lung Adenocarcinoma in situ Based on CD8-positive T Cell Infiltration
Author(s): Yu Ma- Abstract
Loading... -
+
EP16.01-023 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma
Author(s): Yuan Li- Abstract
Loading... -
+
EP16.01-029 - Inter-tumor Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer
Author(s): Yuichi Saito- Abstract
Loading... -
+
EP16.01-004 - Pleural Mesotheliomas Related with Geographical Asbestos Exposure Show Higher PD-L1 Expression
Author(s): Yusuf Kahya- Abstract
Loading... -
+
EP16.01-030 - Peripheral T-Cell Receptor Repertoire Profiling in Non-small Cell Lung Cancer Using an Amplicon-Based Sequencing Assay
Author(s): Zi Yi Wan- Abstract
Loading... -
+
EP16.01-019 - The Role of the Pregnancy Associated Protein Glycodelin and Its Influence on the Immune System in Non-small-Cell Lung Cancer
Author(s): Sarah Richtmann- Abstract
Loading... -
+
EP16.01-002 - T Cell Receptor Diversity among Non-Small Cell Lung Cancer Patients Treated with Pembrolizumab Alone or in Combination with Chemotherapy.
Author(s): Afaf Abed- Abstract
Loading... -
+
EP16.01-032 - Guiding Monotherapy with Docetaxel or Atezolizumab via the Tumour Mutation Index in Non-small Cell Lung Cancer Patients
Author(s): Jun Lu- Abstract
Loading... -
+
EP16.01-033 - Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated With Immunotherapy
Author(s): Andrea Sesma- Abstract
Loading...
-
+
EP16.02 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
- Presentations: 29
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP16.02-023 - Extracellular Vesicles Long RNA Sequencing as Diagnostic Biomarkers for Lung Adenocarcinoma Patients with Tumor Size Smaller than 2cm
Author(s): Yanwei Zhang- Abstract
Loading... -
+
EP16.02-002 - Circulating Tumor DNA (ctDNA) Changes in Patients With Lung Cancer from a Real-World Prospective Clinico-Genomic (PCG) Study
Author(s): Anne Chiang- Abstract
Loading... -
+
EP16.02-001 - Integration of Primer Exchange Reaction and DNAzyme for Electrochemical Detection of PD-L1-Expressing Exosomes in Lung Cancer
Author(s): Bing Bo- Abstract
Loading... -
+
EP16.02-021 - The Expression of CEACAMs and Serum CEA Levels as Biomarkers of Postoperative Cancer Recurrence in Non-small Cell Lung Cancer
Author(s): Bubse Na- Abstract
Loading... -
+
EP16.02-004 - Clinical Significance and Genomic Characteristics of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma
Author(s): Charles Ricordel- Abstract
Loading... -
+
EP16.02-005 - Liquid Biopsy Detects Genomic Drivers in Non-small Cell Lung Cancer without EGFR Mutations by Single-plex Testing: WJOG13620L
Author(s): Daisuke Hazama- Abstract
Loading... -
+
EP16.02-006 - Evaluation of Carcinoembryonic Antigen (CEA) as Predictive Marker in Patients with Metastatic Non-small Cell Lung Cancer
Author(s): Debapriya Mondal- Abstract
Loading... -
+
EP16.02-007 - Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
Author(s): Estela Sánchez-Herrero- Abstract
Loading... -
+
EP16.02-003 - Real World Experience and Feasibility of Tissue Informed CGP and ctDNA Testing in a Cohort of NSCLC Patients
Author(s): Georges Azzi- Abstract
Loading... -
+
EP16.02-008 - Cerebrospinal Fluid as a Liquid Biopsy for Molecular Characterization of Brain Metastases in Patients With Non-small Cell Lung Cancer
Author(s): Georgios Tsakonas- Abstract
Loading... -
+
EP16.02-016 - Exploration of Factors Affecting the Performance of MRD Tumor-Informed Assay in Chinese Lung Cancer Patients
Author(s): Guomin Lin- Abstract
Loading... -
+
EP16.02-009 - Psychobiological Stress Responses to a Lung Cancer Diagnosis.
Author(s): Hronn Hardardottir- Abstract
Loading... -
+
EP16.02-014 - A Comparative Analysis of Gene Alteration Detected With NGS in Tumor Tissue and Peripheral Blood in Lung Cancer
Author(s): Irene Ozaez- Abstract
Loading... -
+
EP16.02-011 - Liquid Biopsies in the Setting of Early-Stage Lung Cancer for the Detection of Actionable Mutations
Author(s): Joana Espiga de Macedo- Abstract
Loading... -
+
EP16.02-012 - cfDNA Analysis Implementation in Early Stage Lung Cancer
Author(s): Joana Espiga de Macedo- Abstract
Loading... -
+
EP16.02-013 - Retrospective Analysis of BRCA1/2 Alterations in Advanced NSCLC Using An Amplicon-based NGS Liquid Biopsy Assay
Author(s): Jonathan Poh- Abstract
Loading... -
+
EP16.02-026 - Dynamic Change of Indoleamine 2,3-dioxygenase Activity Predicts Survival in Radiotherapy- Received Unresectable Stage III NSCLC
Author(s): Linfang Wu- Abstract
Loading... -
+
EP16.02-015 - Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC
Author(s): Loukia Georgiou Karacosta- Abstract
Loading... -
+
EP16.02-018 - Liquid Biopsies First to Make Treatment Decisions in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC)
Author(s): Luis Raez, MD, FACP, FCCP- Abstract
Loading... -
+
EP16.02-029 - Plasma-Based Next Generation Sequencing for Molecular Characterization of Lung Adenocarcinoma: A Multicentric Cohort From Argentina
Author(s): Martina Paz Spotti- Abstract
Loading... -
+
EP16.02-019 - Metabolic Changes in Sputum and Exhaled Breath Condensate of Non-small Cell Lung Cancer Patients after Surgical Resection
Author(s): Naseer Ahmed- Abstract
Loading... -
+
EP16.02-024 - Plasma ctDNA Organ-Specific Genomic Patterns and Origination Analysis in Advanced Non-Small Cell Lung Cancer
Author(s): Rui Fu- Abstract
Loading... -
+
EP16.02-025 - SerumTumor Markers as a Surrogate forRadiographicAssessment of Non-Small Cell Lung Cancer
Author(s): Scott W Strum- Abstract
Loading... -
+
EP16.02-028 - Schwann Cell Exosomes Promote Lung Cancer Progression via miRNA-21-5P Cargo
Author(s): Yan Zhou- Abstract
Loading... -
+
EP16.02-027 - Targeted Methylation Analysis of Circulating Cell-Free DNA to Predict Outcomes in Clinical Stage I NSCLC Patients
Author(s): Yohan Bossé- Abstract
Loading... -
+
EP16.02-022 - Circulating Tumor DNA Minimal Residual Disease Assay Predicts Outcome in Lung Cancer Patients Who Had Curative Treatments
Author(s): Sung Mi Yoon- Abstract
Loading... -
+
EP16.02-017 - Predictive Value of Peripheral Blood Immune Cell Profiling in EGFR-T790M Mutant Lung Adenocarcinoma
Author(s): Yutao Liu- Abstract
Loading... -
+
EP16.02-020 - Lung Cancer Cell Dynamics Significantly Depended on Blood Cell Circuit, Biochemical Factors, Hemostasis System, Cancer Characteristics
Author(s): Oleg Kshivets- Abstract
Loading... -
+
EP16.02-010 - Predictive Value of Serum Reactive Oxygen Species Modulator 1 for Surgically Resected Lung Adenocarcinoma
Author(s): Seung Hyeun Lee- Abstract
Loading...
first
prev
